Gene · 1215
Papers3,945
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,945
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress. | Antioxidants (Basel) | 2023 | 38001786 | PubTator, text mining | PubMed |
| The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases. | Diagnostics (Basel) | 2023 | 37998534 | PubTator, text mining | PubMed |
| Emerging Role of the Mast Cell-Microbiota Crosstalk in Cutaneous Homeostasis and Immunity. | Cells | 2023 | 37998359 | PubTator, text mining | PubMed |
| Salivary concentrations of secretory leukocyte protease inhibitor and matrix metallopeptidase-9 following a single bout of exercise are associated with intensity and hydration status. | PLoS One | 2023 | 37992002 | PubTator, text mining | PubMed |
| Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. | Gut Microbes | 2023 | 37979154 | PubTator, text mining | PubMed |
| Ixodes scapularis nymph saliva protein blocks host inflammation and complement-mediated killing of Lyme disease agent, Borrelia burgdorferi. | Front Cell Infect Microbiol | 2023 | 37965264 | PubTator, text mining | PubMed |
| Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. | J Transl Med | 2023 | 37964363 | PubTator, text mining | PubMed |
| Associations between abrupt transition, dialysis-requiring AKI, and early mortality in ESKD among U.S. veterans. | BMC Nephrol | 2023 | 37964185 | PubTator, text mining | PubMed |
| Independent and Interactive Roles of Immunity and Metabolism in Aortic Dissection. | Int J Mol Sci | 2023 | 37958896 | PubTator, text mining | PubMed |
| A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis. | Diagnostics (Basel) | 2023 | 37958203 | PubTator, text mining | PubMed |
| Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma. | J Genet Eng Biotechnol | 2023 | 37947895 | PubTator, text mining | PubMed |
| Community-Based Digital Contact Tracing of Emerging Infectious Diseases: Design and Implementation Study With Empirical COVID-19 Cases. | J Med Internet Res | 2023 | 37938887 | PubTator, text mining | PubMed |
| Comparison of Mast Cell Density and Prognostic Factors in Invasive Breast Carcinoma: A Single-Centre Study in Malaysia. | Malays J Med Sci | 2023 | 37928785 | PubTator, text mining | PubMed |
| Pathophysiology of bradykinin and histamine mediated angioedema. | Front Allergy | 2023 | 37920409 | PubTator, text mining | PubMed |
| Editorial: Cell-to-cell communications in alcohol-associated, metabolic-related and viral liver diseases. | Front Physiol | 2023 | 37904795 | PubTator, text mining | PubMed |
| Plant Serpins: Potential Inhibitors of Serine and Cysteine Proteases with Multiple Functions. | Plants (Basel) | 2023 | 37896082 | PubTator, text mining | PubMed |
| The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy. | Int J Mol Sci | 2023 | 37895153 | PubTator, text mining | PubMed |
| Human Periapical Odontogenic Granulomas: Aspects of Microvessel Density (MVD), Heterogeneity of Blood Vessels and Mast Cells Density (MCD). | Biomedicines | 2023 | 37893083 | PubTator, text mining | PubMed |
| The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. | Cancer Cell Int | 2023 | 37891636 | PubTator, text mining | PubMed |
| Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. | Cells | 2023 | 37887317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1215/papers?page=9